C-03 · Anti-Inflammatories

Andrographis paniculata

Andrographolide

What to know

A double-blind trial found the standardized extract HMPL-004 comparable to mesalazine in active UC; a 224-patient placebo-controlled trial then found 60% response at 1,800 mg/day versus 40% on placebo (remission not significantly different). No clean single-ingredient product on Fullscript.
References 47–49

Evidence & Andrew’s score

Evidence
4
Andrew
—

Product selection

no product
—

References

  1. Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant therapy in patients with inflammatory bowel disease. Ann Gastroenterol 2015;28(2):210–220.
  2. Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis, a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther 2011;33(2):194–202.
  3. Sandborn WJ, Targan SR, Byers VS, et al. Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol 2013;108(1):90–98. (224 patients; response 60% on 1,800 mg/day vs 40% placebo; remission 38% vs 25%, not significant.)

READ & SHOP

Explore related supplements

Browse all 100 →

Options to explore with your care team. These are not a recommendation to take them together. Andrew earns a commission on Fullscript purchases. US shipping only.